New imaging probe tracks prostate cancer and may enable earlier treatment

Researchers developed a new imaging probe to track prostate cancer by detecting androgen receptors, potentially enabling earlier and more effective treatment before resistance emerges. The probe, named ARi-FL, is stable and can detect androgen receptors even with mutations, offering a more reliable method for monitoring the cancer's progression. This advancement could help doctors choose treatments sooner, addressing the challenge of drug resistance that leads to more lethal stages of prostate cancer.